AIMS: To examine the rate of macular thickness loss using time-domain optical coherence tomography (OCT) in functionally progressing versus non-progressing eyes, determined by standard automated perimetry (SAP). METHODS: Glaucoma suspects (GS) and glaucomatous (G) eyes underwent SAP and OCT imaging every 6 months. Functional progression was determined using pointwise linear regression, defined as 2 contiguous locations losing ≥1.0 dB/year at P<1.0% in the same hemifield. The annual rate of macular thickness loss was calculated from inner and outer regions of the macular map. RESULTS: 72 eyes (43 GS and 29G) with ≥30 months of follow-up were enrolled. Fourteen eyes demonstrated SAP progression. The annual rate of macular thickness loss (μm/year) in progressing eyes was faster (all P<0.05) than non-progressing eyes in temporal outer (-1.90±2.97 vs 0.33±2.77), nasal inner (-1.70±2.66 vs 0.14±2.76), superior inner (-2.15±4.57 vs 0.51±2.99), temporal inner quadrants (-2.58±5.05 vs -0.38±2.34), and the average of inner macular quadrants (-1.84±2.90 vs 0.03±2.10). The rate of loss in the nasal inner (P=0.02) and temporal outer (P=0.02) macular regions was associated with optic disc haemorrhage. CONCLUSIONS: Eyes with SAP progression have significantly greater rates of macular thickness loss consistent with glaucomatous retinal ganglion cell atrophy, as compared with non-progressing eyes.
AIMS: To examine the rate of macular thickness loss using time-domain optical coherence tomography (OCT) in functionally progressing versus non-progressing eyes, determined by standard automated perimetry (SAP). METHODS:Glaucoma suspects (GS) and glaucomatous (G) eyes underwent SAP and OCT imaging every 6 months. Functional progression was determined using pointwise linear regression, defined as 2 contiguous locations losing ≥1.0 dB/year at P<1.0% in the same hemifield. The annual rate of macular thickness loss was calculated from inner and outer regions of the macular map. RESULTS: 72 eyes (43 GS and 29G) with ≥30 months of follow-up were enrolled. Fourteen eyes demonstrated SAP progression. The annual rate of macular thickness loss (μm/year) in progressing eyes was faster (all P<0.05) than non-progressing eyes in temporal outer (-1.90±2.97 vs 0.33±2.77), nasal inner (-1.70±2.66 vs 0.14±2.76), superior inner (-2.15±4.57 vs 0.51±2.99), temporal inner quadrants (-2.58±5.05 vs -0.38±2.34), and the average of inner macular quadrants (-1.84±2.90 vs 0.03±2.10). The rate of loss in the nasal inner (P=0.02) and temporal outer (P=0.02) macular regions was associated with optic disc haemorrhage. CONCLUSIONS: Eyes with SAP progression have significantly greater rates of macular thickness loss consistent with glaucomatous retinal ganglion cell atrophy, as compared with non-progressing eyes.
Authors: Christopher C Teng; Carlos Gustavo De Moraes; Tiago S Prata; Craig A Liebmann; Celso Tello; Robert Ritch; Jeffrey M Liebmann Journal: Ophthalmology Date: 2011-09-01 Impact factor: 12.079
Authors: Carlos Gustavo V De Moraes; Viral J Juthani; Jeffrey M Liebmann; Christopher C Teng; Celso Tello; Remo Susanna; Robert Ritch Journal: Arch Ophthalmol Date: 2011-05
Authors: Christopher Kai Shun Leung; Shu Liu; Robert N Weinreb; Gilda Lai; Cong Ye; Carol Yim Lui Cheung; Chi Pui Pang; Kwok Kay Tse; Dennis Shun Chiu Lam Journal: Ophthalmology Date: 2011-04-29 Impact factor: 12.079
Authors: Christopher Kai-Shun Leung; Vivian Chiu; Robert N Weinreb; Shu Liu; Cong Ye; Marco Yu; Carol Yim-Lui Cheung; Gilda Lai; Dennis Shun-Chiu Lam Journal: Ophthalmology Date: 2011-04-29 Impact factor: 12.079
Authors: Felipe A Medeiros; Linda M Zangwill; Luciana M Alencar; Christopher Bowd; Pamela A Sample; Remo Susanna; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2009-10-08 Impact factor: 4.799
Authors: Christopher Kai-shun Leung; Carol Yim Lui Cheung; Robert N Weinreb; Kunliang Qiu; Shu Liu; Haitao Li; Guihua Xu; Ning Fan; Chi Pui Pang; Kwok Kay Tse; Dennis Shun Chiu Lam Journal: Invest Ophthalmol Vis Sci Date: 2009-08-13 Impact factor: 4.799
Authors: Donald L Budenz; Julia Beiser Huecker; Steven J Gedde; Mae Gordon; Michael Kass Journal: Am J Ophthalmol Date: 2016-11-07 Impact factor: 5.258